Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer (IBIS II)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Queen Mary University of London
ClinicalTrials.gov Identifier:
NCT00078832
First received: March 8, 2004
Last updated: August 5, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2022
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)